Gene · 1272
Papers1,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anti-Contactin-1-Associated Membranous Nephropathy Presenting With Subsequent Autoimmune Nodopathy. | Kidney Med | 2026 | 42787889 | PubTator, text mining | PubMed |
| The clinical features of anti-CNTN1 antibodies associated autoimmune nodopathies with nephropathy: a case series. | Front Neurol | 2026 | 42755838 | PubTator, text mining | PubMed |
| Pathophysiology and Emerging Therapies in Chronic Inflammation Demyelinating Polyneuropathy. | Intern Med | 2026 | 42749655 | PubTator, text mining | PubMed |
| Beyond Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Anti-Contactin-1 Autoimmune Nodopathy Unmasked by Proteinuria. | J Clin Med | 2026 | 42652648 | PubTator, text mining | PubMed |
| Anti-Contactin-1 Nodopathy Presenting With Dysphagia and Nephrotic Syndrome: Remarkable Neurological and Renal Recovery Following Early B-Cell-Targeted Therapy. | Neurologist | 2026 | 42594268 | PubTator, text mining | PubMed |
| Neuro-renal syndrome (NRS) in autoimmune nodopathies and paranodopathies: A warning to consider the diagnosis when anti-node and paranode antibody tests are difficult to perform. | J Neurol Sci | 2026 | 42497634 | PubTator, text mining | PubMed |
| Autoimmune nodopathies: a clinical review. | Clin Neurophysiol | 2026 | 42492459 | PubTator, text mining | PubMed |
| CNTN-1 regulates malignant biological behaviors of lung squamous cell carcinoma (LUSC) via the endoplasmic reticulum stress (ERS)/epithelial-mesenchymal transition (EMT) axis. | Transl Cancer Res | 2026 | 42445425 | PubTator, text mining | PubMed |
| Mining biomarkers for type 2 diabetic nephropathy based on urinary proteomics and metabolomics. | Front Endocrinol (Lausanne) | 2026 | 42440498 | PubTator, text mining | PubMed |
| Development and Inter-Laboratory Validation of Multiplex Flow Cytometry Assay for Autoimmune Nodopathy. | J Peripher Nerv Syst | 2026 | 42437960 | PubTator, text mining | PubMed |
| Anti-MAG-associated neuropathy: a case report and literature review. | BMC Neurol | 2026 | 42436389 | PubTator, text mining | PubMed |
| Contactin-1 Membranous Nephropathy Without Neuropathy and Serum Antibodies. | Kidney Int Rep | 2026 | 42358479 | PubTator, text mining | PubMed |
| Differential Biological and Molecular Profiling of Mesenchymal Progenitor Cells in Cartilage from Osteoarthritis and Rheumatoid Arthritis: An In Vitro Study. | Int J Mol Sci | 2026 | 42352972 | PubTator, text mining | PubMed |
| Clemastine alleviates cognitive dysfunction after SAH by targeting neuronal CNTN1 to regulate the ADA-adenosine pathway. | Acta Pharmacol Sin | 2026 | 42337055 | PubTator, text mining | PubMed |
| Specific HLA-DRB1 Alleles Associate With Anti-Caspr1 and Anti-CNTN1 Autoantibodies in Autoimmune Nodopathies. | Neurol Neuroimmunol Neuroinflamm | 2026 | 42335443 | PubTator, text mining | PubMed |
| Contactin-1-Associated Membranous Nephropathy after Multiple mRNA 1273 COVID-19 Vaccinations: A Case Report. | Glomerular Dis | 2026 | 42294512 | PubTator, text mining | PubMed |
| Autoimmune nodopathy associated with Sjögren's disease and nephrotic syndrome: a case report and literature review. | Front Immunol | 2026 | 42245643 | PubTator, text mining | PubMed |
| Comprehensive proteomic meta-analysis identifies novel proteomics alterations in proliferative diabetic retinopathy. | Exp Eye Res | 2026 | 42208844 | PubTator, text mining | PubMed |
| Anti-GLDN antibody-associated CIDP (nodopathy): transient IVIg response and B-cell depletion remission. | BMC Neurol | 2026 | 42151911 | PubTator, text mining | PubMed |
| Gene Expression Alterations Associated With Resveratrol-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Osteosarcoma Cancer Cells. | J Cell Mol Med | 2026 | 41937498 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1272/papers